Refine by
Neuromuscular Junction Equipment & Supplies In Ireland
7 equipment items found
Manufactured by:SEQENS Group based inÉcully, FRANCE
Sugammadex is an octasaccharide derivative used for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery. The encapsulation by sugammadex blocks the ability of the neuromuscular blocking agents to bind to nicotinic receptors in the neuromuscular junction and thereby ...
Manufactured by:Allengers Global Healthcare Private Limited based inChandigarh, INDIA
The latest digital technology offers the physician greater flexibility in recording and interpreting EMG, finding diseases that can damage muscle tissue, nerves, or the junctions between nerve and muscle (neuromuscular junction). Electromyography (EMG) is a technique for evaluating and recording the electrical activity produced by skeletal ...
Manufactured by:Allengers Global Healthcare Private Limited based inChandigarh, INDIA
Allengers Scorpio Series of EMG, EP test system are designed using state-of-the-art technology for Innovation of using computer technology to record the EMG, EP and NCS has brought diagnostic neurology to the edge of the 21st century finding diseases that damage muscle tissue, nerves, or the junctions between nerve and muscle (neuromuscular ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
α-CGRP (mouse, rat), a neuropeptide (calcitonin gene-related peptide (CGRP)) mainly expressed in neuromuscular junction, is a potent vasodilator. α-CGRP (mouse, rat) can lead to a fall in blood pressure and an increase in heart rate by peripheral administration, also relax colonie smooth muscle. α-CGRP (mouse, rat) has the potential in cardiovascular, ...
by:CuraVac Europe S.A. based inRixensart, BELGIUM
CuraVac is a clinical-stage biotechnology company developing the medical and commercial potential of a revolutionary technique for the production of specific Therapeutic Vaccines (or Active Targeted Immunotherapies) for autoimmune ...
by:Pure Biologics SA based inWroclaw, POLAND
Myasthenia gravis (MG) is an autoimmune condition classified as a rare disease. Accordingly, myasthenic patients lack effective treatment options, as this rare disease is not a primary interest of the pharmaceutical industry. However, considerable social and institutional support exists for the development of new therapies to treat rare diseases. The PB005 (AptaMG) project aims to develop a novel ...
by:CuraVac Europe S.A. based inRixensart, BELGIUM
The MYASTERIX project (2013 – 2018) advanced a Therapeutic Vaccine candidate (designated orphan drug) indicated for myasthenia gravis (MG) to clinical proof of concept ...